Authors
Meletios Dimopoulos, Robert Kyle, Jean-Paul Fermand, S Vincent Rajkumar, Jesus San Miguel, Asher Chanan-Khan, Heinz Ludwig, Douglas Joshua, Jayesh Mehta, Morie Gertz, Hervé Avet-Loiseau, Meral Beksaç, Kenneth C Anderson, Philippe Moreau, Seema Singhal, Hartmut Goldschmidt, Mario Boccadoro, Shaji Kumar, Sergio Giralt, Nikhil C Munshi, Sundar Jagannath, International Myeloma Workshop Consensus Panel 3
Publication date
2011/5/5
Journal
Blood, The Journal of the American Society of Hematology
Volume
117
Issue
18
Pages
4701-4705
Publisher
American Society of Hematology
Description
A panel of members of the 2009 International Myeloma Workshop developed guidelines for standard investigative workup of patients with suspected multiple myeloma. Both serum and urine should be assessed for monoclonal protein. Measurement of monoclonal protein both by densitometer tracing and/by nephelometric quantitation is recommended, and immunofixation is required for confirmation. The serum-free light chain assay is recommended in all newly diagnosed patients with plasma cell dyscrasias. Bone marrow aspiration and/or biopsy along with demonstration of clonality of plasma cells are necessary. Serum β2-microglobulin, albumin, and lactate dehydrogenase are necessary for prognostic purposes. Standard metaphase cytogenetics and fluorescent in situ hybridization for 17p, t(4;14), and t(14;16) are recommended. The skeletal survey remains the standard method for imaging screening, but …
Total citations
Scholar articles
M Dimopoulos, R Kyle, JP Fermand, SV Rajkumar… - Blood, The Journal of the American Society of …, 2011